Histogen Inc. Common Stock
HSTO
HSTO was delisted on the 4th of October, 2023.
13 hedge funds and large institutions have $90.4K invested in Histogen Inc. Common Stock in 2022 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 3 closing their positions.
0% more funds holding
Funds holding: 13 → 13 (0)
0% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 3
25% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 4
48% less capital invested
Capital invested by funds: $174K → $90.4K (-$83.6K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
+$14.7K |
| 2 |
Renaissance Technologies
New York
|
+$11.8K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
+$7.24K |
| 4 |
Wells Fargo
San Francisco,
California
|
+$50 |
| 5 |
BFEC
Benjamin F. Edwards & Company
St. Louis,
Missouri
|
+$6 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
-$37K |
| 2 |
Prudential Financial
Newark,
New Jersey
|
-$26K |
| 3 |
Morgan Stanley
New York
|
-$3K |
| 4 |
TSS
Two Sigma Securities
New York
|
-$914 |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$884 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
BlackRock
New York
| $29K | +$2 | +2 | +0% |
|
2
Vanguard Group
Malvern,
Pennsylvania
| $11.3K | – | – | – |
|
|
3
Jane Street
New York
| $10.9K | +$14.7K | +13,182 | New |
|
4
Geode Capital Management
Boston,
Massachusetts
| $9K | – | – | – |
|
|
TRCT
5
Tower Research Capital (TRC)
New York
| $9K | +$7.24K | +6,473 | +152% |
|
|
6
Renaissance Technologies
New York
| $9K | +$11.8K | +10,600 | New |
|
|
TSS
7
Two Sigma Securities
New York
| $8.38K | -$914 | -818 | -7% |
|
|
8
UBS Group
Zurich,
Switzerland
| $3.76K | -$884 | -791 | -15% |
|
|
9
Wells Fargo
San Francisco,
California
| $51 | +$50 | +45 | +265% |
|
|
VF
10
Virtu Financial
New York
| – | -$37K | -27,227 | Closed |
|
|
11
Prudential Financial
Newark,
New Jersey
| – | -$26K | -19,400 | Closed |
|
|
12
Morgan Stanley
New York
| – | -$3K | -2,575 | Closed |
|
13
Osaic Holdings
Scottsdale,
Arizona
| – | -$6 | -5 | -1% |
|
14
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | -$3 | -3 | -17% |
|
|
BFEC
15
Benjamin F. Edwards & Company
St. Louis,
Missouri
| – | +$6 | +5 | New |
|
HSTO Hedge Fund Activity: Q4 2022 in Review
13 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Histogen Inc. Common Stock (HSTO) for Q4 2022, worth a combined $90.4K — down 48% from $174K a quarter earlier.
Fund positioning in HSTO was balanced in Q4 2022: 3 funds opened new positions, 3 closed out, 3 added to existing stakes and 4 trimmed.
The largest buyer was Jane Street, opening a new position worth an estimated $14.7K. The largest seller was Virtu Financial, exiting entirely with an estimated $37K sold.
- 13 institutional investors held Histogen Inc. Common Stock (HSTO) as of Q4 2022, unchanged from Q3 2022.
- Funds reported $90.4K of Histogen Inc. Common Stock stock for Q4 2022, down 48% quarter-over-quarter.
- 3 funds opened new Histogen Inc. Common Stock positions in Q4 2022 and 3 closed out, a net change of 0 holders.
- The largest Histogen Inc. Common Stock buyer in Q4 2022 was Jane Street, an estimated $14.7K added.
- The largest Histogen Inc. Common Stock seller in Q4 2022 was Virtu Financial, an estimated $37K sold.
Based on aggregated 13F filings for Q4 2022.